Literature DB >> 19095395

Determination of mirodenafil and sildenafil in the plasma and corpus cavernous of SD male rats.

Sang Kyu Lee1, Yoon Kim, Tae Kon Kim, Guang-Jin Im, Bong-Yong Lee, Dong-Hyun Kim, Changbae Jin, Hye Hyun Yoo.   

Abstract

The purpose of the present study was to determine sildenafil and a novel PDE-5 inhibitor, mirodenafil in the plasma and corpus cavernosum tissue of rats to compare their pharmacokinetic properties. The concentrations of mirodenafil and sildenafil in the rat plasma and corpus cavernosum tissue samples were analyzed using LC-MS/MS after a single oral administration at a dose of 40mg/kg to rats. Although the T(max), Tlambda(1/2) and MRT were not different between mirodenafil and sildenafil, the C(max) and AUC of mirodenafil were significantly higher than those of sildenafil in the plasma and corpus cavernosum tissue. Consequently mirodenafil remained longer than sildenafil in the plasma and tissue. This may provide pharmacokinetic evidence for assessment of the in vivo efficacy of mirodenafil and sildenafil.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095395     DOI: 10.1016/j.jpba.2008.11.004

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Chronic treatment with the phosphodiesterase type 5 inhibitors sildenafil and tadalafil display anxiolytic effects in Flinders Sensitive Line rats.

Authors:  Nico Liebenberg; Brian H Harvey; Linda Brand; Gregers Wegener; Christiaan B Brink
Journal:  Metab Brain Dis       Date:  2012-02-23       Impact factor: 3.584

2.  The effect of mirodenafil on the penile erection and corpus cavernosum in the rat model of cavernosal nerve injury.

Authors:  H Kim; D W Sohn; S D Kim; S-H Hong; H J Suh; C B Lee; S W Kim
Journal:  Int J Impot Res       Date:  2010-09-23       Impact factor: 2.896

Review 3.  A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction.

Authors:  Min Chul Cho; Jae-Seung Paick
Journal:  Ther Adv Urol       Date:  2016-01-19

Review 4.  Mirodenafil for the treatment of erectile dysfunction: a systematic review of the literature.

Authors:  Hyun Jun Park; Kyung Hyun Moon; Seung Wook Lee; Won Ki Lee; Sung Chul Kam; Jun Ho Lee; Nam Cheol Park
Journal:  World J Mens Health       Date:  2014-04-25       Impact factor: 5.400

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.